[HTML][HTML] p53: guardian of ploidy

Y Aylon, M Oren - Molecular oncology, 2011 - Elsevier
Y Aylon, M Oren
Molecular oncology, 2011Elsevier
Aneuploidy, often preceded by tetraploidy, is one of the hallmarks of solid tumors. Indeed,
both aneuploidy and tetraploidy are oncogenic occurrences that are sufficient to drive
neoplastic transformation and cancer progression. True to form, the tumor suppressor p53
obstructs propagation of these dangerous chromosomal events by either instigating
irreversible cell cycle arrest or apoptosis. The tumor suppressor Lats2, along with other
tumor inhibitory proteins such as BRCA1/2 and BubR1, are central to p53-dependent …
Aneuploidy, often preceded by tetraploidy, is one of the hallmarks of solid tumors. Indeed, both aneuploidy and tetraploidy are oncogenic occurrences that are sufficient to drive neoplastic transformation and cancer progression. True to form, the tumor suppressor p53 obstructs propagation of these dangerous chromosomal events by either instigating irreversible cell cycle arrest or apoptosis. The tumor suppressor Lats2, along with other tumor inhibitory proteins such as BRCA1/2 and BubR1, are central to p53-dependent elimination of tetraploid cells. Not surprisingly, these proteins are frequently inactivated or downregulated in tumors, synergizing with p53 inactivation to establish an atmosphere of “tolerance” for a non-diploid state.
Elsevier